ArticleCirculation. Cardiovascular quality and outcomes2019
Thirty-Day Readmission Risk Model for Older Adults Hospitalized With Acute Myocardial Infarction.
Article in Circulation. Cardiovascular quality and outcomes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01755052 (SILVER-AMI), which is not on this map. Cited by 38 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
SILVER-AMI: Risk Stratification in Older Persons With Acute Myocardial Infarction
Who cites it
38 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Association of physical function with hospital readmissions among older adults: A systematic review.Journal of hospital medicine · 2025Pooled it
- Performance of the heart failure risk scores in predicting 1 year mortality and short-term readmission of patients.ESC heart failure · 2023Pooled it
- Factors affecting hospital readmission rates following an acute coronary syndrome: A systematic review.Journal of clinical nursing · 2022Pooled it
- Prediction models for hospital readmissions in patients with heart disease: a systematic review and meta-analysis.BMJ open · 2021Pooled it
- The performance of the Dutch Safety Management System frailty tool to predict the risk of readmission or mortality in older hospitalised cardiac patients.BMC geriatrics · 2021Pooled it
- The nurse-coordinated cardiac care bridge transitional care programme: a randomised clinical trial.Age and ageing · 2021Trial
- The Cardiac Care Bridge randomized trial in high-risk older cardiac patients: A mixed-methods process evaluation.Journal of advanced nursing · 2021Trial
- Trial
- Development and Validation of a Prognostic Model for One-year Mortality in Older Adults with Acute Myocardial Infarction Incorporating Activities of Daily Living Impairment.Clinical interventions in aging · 2026Article
- Development and Validation of Models to Estimate the Incident Risk of Cognitive Impairment and Atherosclerotic Cardiovascular Disease in Older Adults.Journal of the American Heart Association · 2025Article
- Augmenting the Hospital Score with social risk factors to improve prediction for 30-day readmission following acute myocardial infarction.Medical research archives · 2024Article
- Predicting 1 year readmission for heart failure: A comparative study of machine learning and the LACE index.ESC heart failure · 2024Article
- Geriatric assessment-derived deficit accumulation and patient-reported treatment burden in older adults with bladder cancer.Journal of the American Geriatrics Society · 2024Article
- Racial disparities among older adults with acute myocardial infarction: The SILVER-AMI study.Journal of the American Geriatrics Society · 2023Article
- Malignant cancer may increase the risk of all-cause in-hospital mortality in patients with acute myocardial infarction: a multicenter retrospective study of two large public databases.Cardio-oncology (London, England) · 2023Article
- Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registry.Clinical cardiology · 2022Article
- Observational
- In-hospital outcomes and readmission in older adults treated with percutaneous coronary intervention for stable ischemic heart disease.Journal of geriatric cardiology : JGC · 2022Article
- Leveraging Advanced Data Analytics to Predict the Risk of All-Cause Seven-Day Emergency Readmissions.Cureus · 2022Article
- Functional tests in patients with ischemic heart disease.Journal of medicine and life · 2022Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
13 authors.
Funding
Abstract
backgroundEarly readmissions among older adults hospitalized for acute myocardial infarction (AMI) are costly and difficult to predict. Aging-related functional impairments may inform risk prediction but are unavailable in most studies. Our objective was to, therefore, develop and validate an AMI readmission risk model for older patients who considered functional impairments and was suitable for use before hospital discharge. METHODS AND
resultsSILVER-AMI (Comprehensive Evaluation of Risk in Older Adults with AMI) is a prospective cohort study of 3006 patients of age ≥75 years hospitalized with AMI at 94 US hospitals. Participants underwent in-hospital assessment of functional impairments including cognition, vision, hearing, and mobility. Other variables plausibly associated with readmissions were also collected. The outcome was all-cause readmission at 30 days. We used backward selection and Bayesian model averaging to derive (N=2004) a risk model that was subsequently validated (N=1002). Mean age was 81.5 years, 44.4% were women, and 10.5% were nonwhite. Within 30 days, 547 participants (18.2%) were readmitted. Readmitted participants were older, had more comorbidities, and had a higher prevalence of functional impairments, including activities of daily living disability (17.0% versus 13.0%; P=0.013) and impaired functional mobility (72.5% versus 53.6%; P<0.001). The final risk model included 8 variables: functional mobility, ejection fraction, chronic obstructive pulmonary disease, arrhythmia, acute kidney injury, first diastolic blood pressure, P2Y12 inhibitor use, and general health status. Functional mobility was the only functional impairment variable retained but was the strongest predictor. The model was well calibrated (Hosmer-Lemeshow P value >0.05) with moderate discrimination (C statistics: 0.65 derivation cohort and 0.63 validation cohort). Functional mobility significantly improved performance of the risk model (net reclassification improvement index =20%; P<0.001).
conclusionsIn our final risk model, functional mobility, previously not included in readmission risk models, was the strongest predictor of 30-day readmission among older adults after AMI. The modest discrimination indicates that much of the variability in readmission risk among this population remains unexplained by patient-level factors. CLINICAL
trial registrationURL: https://www.clinicaltrials.gov. Unique identifier: NCT01755052.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.